Skip to content
Home
About CROSSJECT
About CROSSJECT
Governance
OUR VALUES
ZENEO® technology
A unique technology platform
Technology for human factors
Clinical effectiveness
PIPELINE
Investors
Company presentation
analyst coverage
Press release
Our news
PROFILE AND FINANCIAL CALENDAR
Newsletter
Career
Contact
X
Home
About us
About CROSSJECT
Governance
Our values
ZENEO® technology
A unique technology platform
Technology for human factors
Clinical effectiveness
PIPELINE
Investors
Company presentation
Press release
Profile and financial calendar
Analyst coverage
Our news
Newsletter
Career
Contact
Français
English
X
Launch of a capital increase with preferential subscription rights for nearly 5 million euros
June 5, 2025
Launch of a capital increase
